| Identification | Back Directory | [Name]
HYLAMBATIN | [CAS]
80890-46-6 | [Synonyms]
HYLAMBATIN
ASP-PRO-PRO-ASP-PRO-ASP-ARG-PHE-TYR-GLY-MET-NH2
ASP-PRO-PRO-ASP-PRO-ASP-ARG-PHE-TYR-GLY-MET-MET-NH2
H-ASP-PRO-PRO-ASP-PRO-ASP-ARG-PHE-TYR-GLY-MET-MET-NH2
L-Asp-L-Pro-L-Pro-L-Asp-L-Pro-L-Asp-L-Arg-L-Phe-L-Tyr-Gly-L-Met-L-Met-NH2 | [Molecular Formula]
C63H90N16O19S2 | [MDL Number]
MFCD00076656 | [MOL File]
80890-46-6.mol | [Molecular Weight]
1439.61 |
| Chemical Properties | Back Directory | [density ]
1.53±0.1 g/cm3(Predicted) | [storage temp. ]
−20°C | [pka]
3.82±0.19(Predicted) | [Sequence]
Asp-Pro-Pro-Asp-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2 |
| Hazard Information | Back Directory | [Uses]
Hylambatin, a tachykinin, increases both plasma glucose and plasma insulin, whereas the secretion of glucagon was not affected. Hylambatin can be used in diabetes research[1]. | [Biological Activity]
Tachykinin th at increases plasma glucose and plasma insulin. | [References]
[1] Güllner HG, et al. Hylambatin, a structurally unique tachykinin: effects on insulin and glucagon secretion. Arch Int Pharmacodyn Ther. 1984 Dec;272(2):304-9. PMID:6395822 |
|
|